Found 32 matching trials
Neoadjuvant Therapy of PD-1 Blockade Combined With Chemotherapy for Esophageal Carcinoma PHASE1 This prospective study aims to clarify the clinical efficacy and survival p...
Show More Learn More & Join Trial
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy PHASE2 The purpose of this study is to establish a prospective, single-center plat...
Show More Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Learn More & Join Trial
Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer PHASE1 RATIONALE: Patients with HER2-negative advanced breast cancer have limited ...
Show More Location
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Learn More & Join Trial
Short-Course Definitive Chemoradiotherapy Combined With Adjuvant or Concurrent Plus Adjuvant Camrelizumab for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma PHASE2 This study aims to compare the efficacy and safety of short-course definiti...
Show More Location
Jiangsu Cancer Hospital /Jiangsu Institute of Cancer Research
Learn More & Join Trial
Neoadjuvant Camrelizumab, Nab-paclitaxel and Carboplatin in Stage IB-IIIA NSCLC PHASE2 This prospective, single-arm, multicenter, phase II trial enrolled 40 patie...
Show More Location
Sun Yat-Sen Memorial Hospital of Sun Yat-sen University
Learn More & Join Trial
A Study of SHR-1210 in Combination With Carboplatin+Paclitaxel-albumin in Subjects With Resectable NSCLC PHASE2 This study is a randomized, controlled, open-label, prospective, single-cen...
Show More Location
Multiple Locations
Learn More & Join Trial
An Organ Preservation Strategies After Chemoradiotherapy Combined With Immunotherapy for Esophageal Cancer (PALACE3). PHASE3 Patients with locally advanced esophageal squamous cell carcinoma will rand...
Show More Learn More & Join Trial
Camrelizumab Combined With SRT/WBRT and Chemotherapy in Patients With Brain Metastases of Driven Gene-negative NSCLC PHASE3 This study is a randomized, double-blind, placebo-controlled, multi-center ...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01) PHASE3 This is an open, randomized, controlled, multicenter Phase III clinical stu...
Show More Location
Breast cancer institute of Fudan University Cancer Hospital
Learn More & Join Trial
A Study of Camrelizumab Combined With Chemotherapy Β± Thalidomide in First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC) PHASE4 To explore and evaluate the safety and efficacy of camrelizumab combined wi...
Show More Location
Multiple Locations
Learn More & Join Trial